MNDL Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

MNDL Bio General Information

Description

Developer of a computational platform designed to optimize the gene expression process. The company's platform utilizes AI to analyze and optimize the production of recombinant proteins, enabling researchers to significantly accelerate development timelines and reduce costs.

Contact Information

Website
www.mndl.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Vainshel 19
  • Tel Aviv 6941338
  • Israel
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
FoodTech, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Vainshel 19
  • Tel Aviv 6941338
  • Israel

MNDL Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MNDL Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator 08-May-2025 Completed Generating Revenue
7. Seed Round 01-Jul-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Jun-2024 Completed Generating Revenue
5. Accelerator/Incubator 06-Mar-2024 Completed Generating Revenue
4. Grant 01-Jul-2023 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2023 $10K $10K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view MNDL Bio’s complete valuation and funding history, request access »

MNDL Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MNDL Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ignite DeepTech Accelerator/Incubator
CPT Capital Venture Capital Minority
Earth & Beyond Ventures Venture Capital Minority
Innovation Authority Government Minority
EIT Food Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

MNDL Bio FAQs

  • When was MNDL Bio founded?

    MNDL Bio was founded in 2023.

  • Where is MNDL Bio headquartered?

    MNDL Bio is headquartered in Tel Aviv, Israel.

  • What is the size of MNDL Bio?

    MNDL Bio has 10 total employees.

  • What industry is MNDL Bio in?

    MNDL Bio’s primary industry is Discovery Tools (Healthcare).

  • Is MNDL Bio a private or public company?

    MNDL Bio is a Private company.

  • What is MNDL Bio’s current revenue?

    The current revenue for MNDL Bio is .

  • How much funding has MNDL Bio raised over time?

    MNDL Bio has raised $2.02M.

  • Who are MNDL Bio’s investors?

    Ignite DeepTech, CPT Capital, Earth & Beyond Ventures, Innovation Authority, and EIT Food are 5 of 11 investors who have invested in MNDL Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process